SEC Form 4 · accession 0001635088-26-000069
Roivant Sciences Ltd. · ROIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Pulik
Officer — CFO
Period of report
Jun 20, 2026
Accepted (ET)
Jun 23, 2026 · 9:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001635088
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jun 20, 2026 | F | 2,129 | $31.43 | D | 276,420 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.